Our findings underscore the pleiotropic role of ATXN2 in the parkinsonian spectrum, with intermediate CAG repeat expansions (≥27 repeats) significantly associated with PD and observed across various neurodegenerative phenotypes, including PSP, CBD, and MSA-P. Here, ATXN2 is linked to supranuclear palsy, progressive, 1.